Prulifloxacin ECG study.
Rosignoli
Maria Teresa
MT
Dionisio
Paolo
P
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001372:Aza Compounds / Q000008:administration & dosage / Q000009:adverse effects; D002986:Clinical Trials as Topic / Q000379:methods; D004148:Dioxolanes / Q000008:administration & dosage / Q000009:adverse effects*; D004562:Electrocardiography / Q000379:methods; D024841:Fluoroquinolones / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D000077266:Moxifloxacin; D010879:Piperazines / Q000008:administration & dosage / Q000009:adverse effects*; D011804:Quinolines / Q000008:administration & dosage / Q000009:adverse effects
D000900:Anti-Bacterial Agents; D001372:Aza Compounds; D004148:Dioxolanes; D024841:Fluoroquinolones; D010879:Piperazines; D011804:Quinolines; C074191:prulifloxacin; D000077266:Moxifloxacin